AI assistant
ANGIODYNAMICS INC — Director's Dealing 2024
Dec 4, 2024
32939_dirs_2024-12-04_47d25abb-978c-4006-b7a1-6dd2274bd919.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2024-12-02
Reporting Person: Weiss Lawrence T (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-02 | Common Stock | A | 52697 | — | Acquired | 52697 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-02 | Non-Qualified Stock Option (right to buy) | $7.14 | A | 103650 | Acquired | 2034-12-02 | Common Stock (103650) | Direct |
Footnotes
F1: The acquisition of 52,697 shares of common stock ("Common Stock") of AngioDynamics, Inc.("AngioDynamics") represents 52,697 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on December 2, 2025, such that 25% of the restricted stock units will vest on each of December 2, 2025, 2026, 2027 and 2028.
F2: These stock options vest in four equal annual installments beginning on December 2, 2025, such that 25% of the options will vest on each of December 2, 2025, 2026, 2027 and 2028.